STOCK TITAN

[Form 3] IDEXX LABORATORIES INC /DE Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

IDEXX Laboratories (IDXX) filed a Form 3 showing initial beneficial ownership by a reporting person who is a Director. The filing reports 0 shares of Common Stock beneficially owned (Direct) and no derivative securities listed in Table II. The date of the event requiring the statement is 10/06/2025, and the form was filed by one reporting person. The submission is signed by Karen Peacock on 10/14/2025.

IDEXX Laboratories (IDXX) ha presentato una Form 3 che mostra la proprietà beneficiaria iniziale da parte di una persona segnalante che è un Direttore. Il modulo riporta 0 azioni ordinarie detenute direttamente e nessun titolo derivato elencato nella Tabella II. La data dell'evento che obbliga la dichiarazione è il 10/06/2025, e il modulo è stato presentato da una sola persona segnalante. Il documento è firmato da Karen Peacock il 14/10/2025.

IDEXX Laboratories (IDXX) presentó un Form 3 que muestra la propiedad beneficiosa inicial por parte de una persona reportante que es un Director. El registro reporta 0 acciones de Acciones Comunes beneficiosamente poseídas (Directas) y ningún valor derivado listado en la Tabla II. La fecha del evento que requiere la declaración es el 06/10/2025, y el formulario fue presentado por una sola persona reportante. La presentación está firmada por Karen Peacock el 14/10/2025.

IDEXX Laboratories (IDXX)가 Form 3를 제출했습니다 보고자 중 한 명이 이사인 초기 유익한 소유를 보여줍니다. 제출 보고서는 직접적으로 보유한 일반주 0주 및 표 II에 기재된 파생증권이 없습니다. 주장서를 요구하는 사건의 날짜는 2025년 10월 6일, 그리고 이 양식은 한 명의 보고자가 제출했습니다. 제출은 Karen Peacock이 2025년 10월 14일에 서명했습니다.

IDEXX Laboratories (IDXX) a déposé un Form 3 montrant la propriété bénéficiaire initiale par une personne déclarant qui est un Directeur. Le dépôt indique 0 actions ordinaires détenues directement et aucun titre dérivé répertorié dans le tableau II. La date de l’événement rendant la déclaration nécessaire est le 06/10/2025, et le formulaire a été déposé par une seule personne déclarant. La soumission est signée par Karen Peacock le 14/10/2025.

IDEXX Laboratories (IDXX) hat Form 3 eingereicht und zeigt die anfängliche unmittelbare Eigentümerschaft einer meldenden Person, die ein Direktor ist. Die Einreichung meldet 0 Aktien der Stammaktien, direkt gehalten und keine derivativen Wertpapiere, die in Tabelle II aufgeführt sind. Das Datum des Ereignisses, das die Angabe erfordert, ist der 06.10.2025, und das Formular wurde von einer meldenden Person eingereicht. Die Einreichung ist von Karen Peacock am 14.10.2025 unterschrieben.

إي دي إي إكس Laboratories (IDXX) قدمت نموذج 3 يعرض الملكية المفيدة الأولية من قِبل شخص مُبلِّغ عنه وهو مدير. يُظهر التقديم 0 أسهم من الأسهم العادية يمتلكها مباشرة ولا توجد أية أدوات مشتقة مدرجة في الجدول II. تاريخ الحدث الذي يستلزم الإقرار هو 10/06/2025، وتم تقديم النموذج بواسطة شخص واحد مُبلِّغ عنه. تم توقيع الإرسال بواسطة كارين بيكو في 10/14/2025.

Positive
  • None.
Negative
  • None.

IDEXX Laboratories (IDXX) ha presentato una Form 3 che mostra la proprietà beneficiaria iniziale da parte di una persona segnalante che è un Direttore. Il modulo riporta 0 azioni ordinarie detenute direttamente e nessun titolo derivato elencato nella Tabella II. La data dell'evento che obbliga la dichiarazione è il 10/06/2025, e il modulo è stato presentato da una sola persona segnalante. Il documento è firmato da Karen Peacock il 14/10/2025.

IDEXX Laboratories (IDXX) presentó un Form 3 que muestra la propiedad beneficiosa inicial por parte de una persona reportante que es un Director. El registro reporta 0 acciones de Acciones Comunes beneficiosamente poseídas (Directas) y ningún valor derivado listado en la Tabla II. La fecha del evento que requiere la declaración es el 06/10/2025, y el formulario fue presentado por una sola persona reportante. La presentación está firmada por Karen Peacock el 14/10/2025.

IDEXX Laboratories (IDXX)가 Form 3를 제출했습니다 보고자 중 한 명이 이사인 초기 유익한 소유를 보여줍니다. 제출 보고서는 직접적으로 보유한 일반주 0주 및 표 II에 기재된 파생증권이 없습니다. 주장서를 요구하는 사건의 날짜는 2025년 10월 6일, 그리고 이 양식은 한 명의 보고자가 제출했습니다. 제출은 Karen Peacock이 2025년 10월 14일에 서명했습니다.

IDEXX Laboratories (IDXX) a déposé un Form 3 montrant la propriété bénéficiaire initiale par une personne déclarant qui est un Directeur. Le dépôt indique 0 actions ordinaires détenues directement et aucun titre dérivé répertorié dans le tableau II. La date de l’événement rendant la déclaration nécessaire est le 06/10/2025, et le formulaire a été déposé par une seule personne déclarant. La soumission est signée par Karen Peacock le 14/10/2025.

IDEXX Laboratories (IDXX) hat Form 3 eingereicht und zeigt die anfängliche unmittelbare Eigentümerschaft einer meldenden Person, die ein Direktor ist. Die Einreichung meldet 0 Aktien der Stammaktien, direkt gehalten und keine derivativen Wertpapiere, die in Tabelle II aufgeführt sind. Das Datum des Ereignisses, das die Angabe erfordert, ist der 06.10.2025, und das Formular wurde von einer meldenden Person eingereicht. Die Einreichung ist von Karen Peacock am 14.10.2025 unterschrieben.

إي دي إي إكس Laboratories (IDXX) قدمت نموذج 3 يعرض الملكية المفيدة الأولية من قِبل شخص مُبلِّغ عنه وهو مدير. يُظهر التقديم 0 أسهم من الأسهم العادية يمتلكها مباشرة ولا توجد أية أدوات مشتقة مدرجة في الجدول II. تاريخ الحدث الذي يستلزم الإقرار هو 10/06/2025، وتم تقديم النموذج بواسطة شخص واحد مُبلِّغ عنه. تم توقيع الإرسال بواسطة كارين بيكو في 10/14/2025.

IDEXX Laboratories (IDXX) 已提交 Form 3,显示报告人(其为董事)的初始受益所有权。该申报报告直接持有的普通股为0股,且表II中未列出衍生证券。引发该声明的事件日期为2025/10/06,该表格由一名报告人提交。该提交由Karen Peacock2025/10/14签署。

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Peacock Karen

(Last) (First) (Middle)
ONE IDEXX DRIVE

(Street)
WESTBROOK ME 04092

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/06/2025
3. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 0 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Karen Peacock 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
IDEXX Laboratories

NASDAQ:IDXX

IDXX Rankings

IDXX Latest News

IDXX Latest SEC Filings

IDXX Stock Data

50.22B
79.45M
0.68%
97.52%
2.56%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
WESTBROOK